Christos Toumpanakis

Royal Free London NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

45h-index8.1kcitations350works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine Tumor Research Advances(294), Lung Cancer Research Studies(203), Neuroblastoma Research and Treatments(135), Pancreatic and Hepatic Oncology Research(65), Gastrointestinal Tumor Research and Treatment(45)

Publications346 total

Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025Open Access
Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025Open Access
Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025Open Access
Figure 5 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025Open Access
Figure 4 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025Open Access
Figure 3 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025Open Access
Haematological toxicity after peptide receptor radionuclide therapy in neuroendocrine tumours - a 10 year experience from south wales
Endocrine Abstracts·2025
Impact of PRRT on quality of life in gastroenteropancreatic neuroendocrine tumours
Endocrine Abstracts·2025
Outcomes of surgical resection for small bowel neuroendocrine tumors: a single-center recent experience
Endocrine Abstracts·2025
The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm
Digestive and Liver Disease·2025· 2 citedOpen Access
Endoscopic submucosal dissection for gastric neuroendocrine neoplasms: A multicenter retrospective study
Journal of Neuroendocrinology·2025
[<sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study
Journal of Nuclear Medicine·2025· 1 cited
OC.07.4 THE INDOLENT NATURE OF TYPE 1 GASTRIC NEUROENDOCRINE TUMOURS UNDER 1 CM: INSIGHTS FROMA DUAL-CENTER STUDY
Digestive and Liver Disease·2025
BOC.01.10 PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC SMALL INTESTINAL NEUROENDOCRINE TUMOURS UNDERGOING PRIMARY TUMOUR RESECTION
Digestive and Liver Disease·2025
OC.18.4 MANAGEMENT STRATEGIES AND OUTCOMES FOR TYPE 1 GASTRIC NEUROENDOCRINE TUMORS MEASURING &gt;1 CM IN DIAMETER
Digestive and Liver Disease·2025
Sex-based disparities in small intestinal neuroendocrine tumors: correlation with mesenteric metastases development?
Endocrine Abstracts·2025
The Indolent Nature of Type 1 Gastric Neuroendocrine Tumours Under 1 cm: Insights from a Dual-Center Study
Endoscopy·2025
Management Strategies and Outcomes for Type 1 Gastric Neuroendocrine Tumors Measuring&gt;1cm in Diameter
Endoscopy·2025
Clinical Outcomes of Patients with Rectal Neuroendocrine Tumors smaller than 10 mm after Endoscopic Resection
Endoscopy·2025
Octreotide infusion pump in patients with functional neuroendocrine tumors and refractory hormonal syndrome
Endocrine Oncology·2025Open Access
page 1 of 18Next →

Frequent Co-authors

Martyn Caplin(34), Tu Vinh Luong(9), Tim Meyer(9), Joseph Davar(8), Massimo Falconi(7), Gregory Kaltsas(7), Ulrich Knigge(7), John Ramage(7), Andrea Frilling(7), Kjell Öberg(6), Aurel Perren(6), Sanjeev Bhattacharyya(6), Christina Thirlwell(6), Stefano Partelli(5), Francesco Panzuto(5), Jarosław B. Ćwikła(4), Réza Kianmanesh(4), Dermot O’Toole(4), Bruno Niederle(4), Anne Couvelard(4)